EJCPharmacy

Former: Atención Farmacéutica.
A journal for clinical pharmacists, opinion leaders in pharmacotherapy and professionals of clinical management

[EJCPharmacy @EJCPharmacy]

EUROPEAN JOURNAL OF CLINICAL PHARMACY - 2385-409X | MIAR 2018 live. Information Matrix for the Analysis of Journals https://t.co/v3Qtrw219S

[EJCPharmacy @EJCPharmacy]

Cutaneous lupus erythematosus induced by infliximab in patient with crohn's disease. A case report.
https://t.co/HJ3XrYLhf0

[EJCPharmacy @EJCPharmacy]

Hospital pharmacy resident rotation in a long-stay psychiatric hospital in the USA.
https://t.co/rMqygm9EY7

[EJCPharmacy @EJCPharmacy]

Treatment of alveolar proteinosis with "Off-Label", inhaled sargramostim.
https://t.co/WllOWmokhV

[EJCPharmacy @EJCPharmacy]

The benefits and risks of statins for primary prevention of mortality and cardiovascular events: umbrella review.
https://t.co/euz15wono8

[EJCPharmacy @EJCPharmacy]

Evaluation of the clinical pharmacist role in a health care team: a comparative approach.
https://t.co/BEpFHWsvgD

[EJCPharmacy @EJCPharmacy]

Effectiveness of vemurafenib in metastatic melanoma
https://t.co/vp7MbRKaQy

[EJCPharmacy @EJCPharmacy]

Influence of pill burden on adherence and effectiveness in patients treated with antiretroviral therapy.
https://t.co/33nByPWvzx

[EJCPharmacy @EJCPharmacy]

Innapropriate prescribing to older patiens admitted to private Hospital
https://t.co/Gtetol0MOt

[EJCPharmacy @EJCPharmacy]

Vol 18. Num.5
The clinical outcome of simvastatin plus standard therapy...
https://t.co/2gg8iAjkgr

[EJCPharmacy @EJCPharmacy]

Vol.18 - Num.5
Approval of New Drugs - Editorial
https://t.co/LDMjG8IJT2

[EJCPharmacy @EJCPharmacy]

DRUG-DRUG INTERACTIONS IN PAEDIATRIC SETTINGhttp://www.farmclin.com/seccion.asp?Id=8&articulo=1122

[EJCPharmacy @EJCPharmacy]

PRESCRIPTION ADALATH: A NOVEL INTERVENTIONAL APPROACH OF CLINICAL PHARMACY SERVICES
https://t.co/HSOChCmqby

[EJCPharmacy @EJCPharmacy]

MECHANISM OF ACTION OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM FOR CLINICAL APPLICATION
https://t.co/QNHoOStBX8

[EJCPharmacy @EJCPharmacy]

STUDY ON THE USE OF RESTRICTED ANTIBIOTICS IN AN INTENSIVE CARE UNIT
https://t.co/aLhdYL0qjM

[EJCPharmacy @EJCPharmacy]

PHARMACEUTICAL CARE IN PATIENTS WITH CONSTIPATION FROM THE PHARMACY.
https://t.co/IuX9k0CLFR

[EJCPharmacy @EJCPharmacy]

OMALIZUMAB EVALUATION OF USE IN A PNEUMOLOGY SERVICE
https://t.co/A4APMwJA7m

[EJCPharmacy @EJCPharmacy]

OUTCOMES PUBLICATION OF RHEUMATOLOGY CLINICAL TRIALS COMPLETED OVER A TEN-YEAR PERIOD
https://t.co/J7oKmlGO3C

[EJCPharmacy @EJCPharmacy]

RISK FACTORS FOR FEBRILE NEUTROPENIA ADMISSIONS ASSOCIATED WITH CHEMOTHERAPY
https://t.co/9rkNs6eKe6

[EJCPharmacy @EJCPharmacy]

PILOT STUDY FOR CARDIOVASCULAR RISK ASSESSMENT IN COMMUNITY PHARMACIES IN COORDINATION WITH A PRIVATE...
https://t.co/LdHbbKNio1